CORTICOSTEROIDS›CORTICOSTEROID
COMBINATIONS WITH ANTI-INFECTIVES
Betamethasone with neomycin
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, betamethasone p. 691 , neomycin sulfate
p. 690.
lINDICATIONS AND DOSE
Eczematous inflammation in otitis externa
▶TO THE EAR USING EAR DROPS
▶Child:Apply 2 – 3 drops 3 – 4 times a day
lCONTRA-INDICATIONSPatent grommet (although may be
used by specialists, see Ear p. 688 ).perforated tympanic
membrane (although may be used by specialists, see Ear
p. 688 )
lCAUTIONSAvoid prolonged use
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ear/eye/nose drops solution
EXCIPIENTS:May contain Benzalkonium chloride, disodium edetate
▶Betnesol-N(RPH Pharmaceuticals AB)
Betamethasone (as Betamethasone sodium phosphate) 1 mg per
1 ml, Neomycin sulfate 5 mg per 1 mlBetnesol-N ear/eye/nose
drops| 10 mlP£ 2. 39 DT = £ 2. 39
Dexamethasone with ciprofloxacin
21-Dec-2017
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, ciprofloxacin p. 690.
lINDICATIONS AND DOSE
Acute otitis media in patients with tympanostomy tubes
▶TO THE EAR
▶Child 6 months–17 years:Apply 4 drops twice daily for
7 days
Acute otitis externa
▶TO THE EAR
▶Child 1–17 years:Apply 4 drops twice daily for 7 days
IMPORTANT SAFETY INFORMATION
MHRA/CHM ADVICE: CORTICOSTEROIDS: RARE RISK OF CENTRAL
SEROUS CHORIORETINOPATHY WITH LOCAL AS WELL AS SYSTEMIC
ADMINISTRATION (AUGUST 2017)
See Corticosteroids, general use p. 434.
lCONTRA-INDICATIONSFungal ear infections.viral ear
infections
lCAUTIONSAvoid prolonged use
lSIDE-EFFECTS
▶Common or very commonEar discomfort
▶UncommonEar infection fungal.flushing.irritability.
malaise.otorrhoea.paraesthesia.skin reactions.taste
altered.vomiting
▶Rare or very rareDizziness.headache.hearing
impairment
SIDE-EFFECTS, FURTHER INFORMATIONManufacturer
advises further evaluation of underlying conditions if
otorrhoea persists after a full course, or if at least two
episodes of otorrhoea occur within 6 months.
lPREGNANCYManufacturer advises use only if potential
benefit outweighs risk—no information available.
lBREAST FEEDINGManufacturer advises caution—no
information available.
lPATIENT AND CARER ADVICEManufacturer advises
counselling on administration.
lNATIONAL FUNDING/ACCESS DECISIONS
Scottish Medicines Consortium (SMC) Decisions
TheScottish Medicines Consortiumhas advised (July 2017 )
that dexamethasone with ciprofloxacin (Cilodex®)is
accepted for restricted use within NHS Scotland for the
treatment of acute otitis media in patients with
tympanostomy tubes (AOMT).
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ear drops
EXCIPIENTS:May contain Benzalkonium chloride, disodium edetate
▶Cilodex(Novartis Pharmaceuticals UK Ltd)
Dexamethasone 1 mg per 1 ml, Ciprofloxacin (as Ciprofloxacin
hydrochloride) 3 mg per 1 mlCilodex ear drops| 5 mlP£ 6. 12
DT = £ 6. 12
Dexamethasone with framycetin
sulfate and gramicidin 21-Dec-2017
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, framycetin sulfate p. 689.
lINDICATIONS AND DOSE
Eczematous inflammation in otitis externa
▶TO THE EAR
▶Child: 2 – 3 drops 3 – 4 times a day
IMPORTANT SAFETY INFORMATION
MHRA/CHM ADVICE: CORTICOSTEROIDS: RARE RISK OF CENTRAL
SEROUS CHORIORETINOPATHY WITH LOCAL AS WELL AS SYSTEMIC
ADMINISTRATION (AUGUST 2017)
See Corticosteroids, general use p. 434.
lLESS SUITABLE FOR PRESCRIBINGSofradex®is less
suitable for prescribing.
lMEDICINAL FORMS
There can be variation in the licensing of different medicines
containing the same drug.
Ear/eye drops solution
EXCIPIENTS:May contain polysorbates
▶Sofradex(Sanofi)
Gramicidin 50 microgram per 1ml, Dexamethasone (as
Dexamethasone sodium metasulfobenzoate) 500 microgram per
1 ml, Framycetin sulfate 5mg per 1 mlSofradex ear/eye drops|
10 mlP£ 7. 50
Dexamethasone with glacial acetic
acid and neomycin sulfate 21-Dec-2017
The properties listed below are those particular to the
combination only. For the properties of the components
please consider, neomycin sulfate p. 690.
lINDICATIONS AND DOSE
Eczematous inflammation in otitis externa
▶TO THE EAR
▶Child 2–17 years:Apply 1 spray 3 times a day
IMPORTANT SAFETY INFORMATION
MHRA/CHM ADVICE: CORTICOSTEROIDS: RARE RISK OF CENTRAL
SEROUS CHORIORETINOPATHY WITH LOCAL AS WELL AS SYSTEMIC
ADMINISTRATION (AUGUST 2017)
See Corticosteroids, general use p. 434.
692 Otitis externa BNFC 2018 – 2019
Ear, nose and oropharynx
12